Early Onset of Antipsychotic Action in Schizophrenia: Evaluating the Possibility of Shorter Acute Efficacy Trials

Extended placebo-controlled clinical trials in schizophrenia research pose an ethical challenge. This study examines factors that have implications for the design and duration of placebo-controlled acute efficacy trials: Does early response discriminate active drug (AD) from placebo, and are the ear...

Ausführliche Beschreibung